NCT06224023 Predictive Values of Presepsin Levels in ASciteS in Patients With Chronic Liver Failure
| NCT ID | NCT06224023 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Carol Davila University of Medicine and Pharmacy |
| Condition | Ascites Hepatic |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2024-08-01 |
| Primary Completion | 2024-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2024-08-01 with a primary completion date of 2024-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators aim to study the predictive value of presepsin in ascites in newly admitted patients with chronic liver failure.
Eligibility Criteria
Inclusion Criteria: * patient with ascites and chronic liver failure * no contraindications and technical possibility to perform diagnostic paracentesis * age above 18 years old * informed consent Exclusion Criteria: * contraindications to paracentesis or technical impossibility to perform paracentesis * absence of informed consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06224023 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Ascites Hepatic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06224023 currently recruiting?
Yes, NCT06224023 is actively recruiting participants. Contact the research team at ciocirlanm@yahho.com for enrollment information.
Where is the NCT06224023 trial being conducted?
This trial is being conducted at Bucharest, Romania.
Who is sponsoring the NCT06224023 clinical trial?
NCT06224023 is sponsored by Carol Davila University of Medicine and Pharmacy. The trial plans to enroll 30 participants.